Integrated light production, saline controls and nitrergic drugs
| Saline (Mq s–1) | Treatment (Mq s–1) | |
|---|---|---|
| SNP (0.3 mmol l–1) | 19.6±13.3 (N=8) | 18.5±9.6 (N=5) |
| SNP (0.03 mmol l–1) | 19.6±13.3 (N=8) | 7.2±6.0 (N=5) |
| SNAP (0.3 mmol l–1) | 3.1±2.1 (N=10) | 348.5±338.9 (N=11) |
| l-NAME (3 mmol l–1) | 4.2±3.7 (N=12) | 3.1±1.4 (N=12) |
| cGMP (0.03 mmol l–1) | 1.1±0.6 (N=10) | 2.1±1.1 (N=10) |
Integrated light production, 10 min; Mq, megaquanta
None of the NO donors or NOS inhibitors had a significant effect per se on the light production compared with the saline control. The high variation in the SNAP response is caused by one specimen responding to the treatment